PDSB Valuation

PDS Biotechnology Corp

Add to Watchlist

Advanced Chart

1.180

-0.03(-2.479%)1D

Overview
Forecast
Valuation
Earnings

PDSB Relative Valuation

PDSB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PDSB is overvalued; if below, it's undervalued.

Historical Valuation

PDS Biotechnology Corp (PDSB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -5.00. The fair price of PDS Biotechnology Corp (PDSB) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：1.21

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.46

P/B

Median3y

4.22

Median5y

3.99

-59.77

FCF Yield

Median3y

-28.16

Median5y

-22.18

Competitors Valuation Multiple

The average P/S ratio for PDSB's competitors is 34.55, providing a benchmark for relative valuation. PDS Biotechnology Corp Corp (PDSB) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

PDSB.O

PDS Biotechnology Corp

Loss

Average P/S: 34.55

53.94M